Renalytix plc Foreign Currency Transaction Gain (Loss), Unrealized
Renalytix plc (RENXF) reported Foreign Currency Transaction Gain (Loss), Unrealized of $0 for the 12-month period ending 2024-06-30, per its 10-K filed 2024-09-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ForeignCurrencyTransactionGainLossUnrealized · last filed 2024-09-30
- Renalytix plc foreign currency transaction gain (loss), unrealized for the quarter ending 2024-06-30 was $0.00, a 100.00% decline year-over-year.
- Renalytix plc foreign currency transaction gain (loss), unrealized for the quarter ending 2024-03-31 was $0.00.
- Renalytix plc foreign currency transaction gain (loss), unrealized for the quarter ending 2023-12-31 was $0.00, a 100.00% decline year-over-year.
- Renalytix plc foreign currency transaction gain (loss), unrealized for the quarter ending 2023-09-30 was $0.00.
- Renalytix plc foreign currency transaction gain (loss), unrealized for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- Renalytix plc foreign currency transaction gain (loss), unrealized for fiscal 2023 was $1.01M, a 86.27% decline from fiscal 2022.
- Renalytix plc foreign currency transaction gain (loss), unrealized for fiscal 2022 was $7.34M.
| Period end | Foreign Currency Transaction Gain (Loss), Unrealized 3 month | Foreign Currency Transaction Gain (Loss), Unrealized 6 month | Foreign Currency Transaction Gain (Loss), Unrealized 9 month | Foreign Currency Transaction Gain (Loss), Unrealized 9 month as first filed | Foreign Currency Transaction Gain (Loss), Unrealized 12 month |
|---|---|---|---|---|---|
| 2024-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-30 | $0.00 derived: sum of 2 quarters · filed 2024-09-30 | $0.00 derived: sum of 3 quarters · filed 2024-09-30 | $0.00 10-K · filed 2024-09-30 | |
| 2024-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-15 | $0.00 derived: sum of 2 quarters · filed 2024-05-15 | $0.00 10-Q · filed 2024-05-15 | $1.33M derived: sum of 4 quarters · filed 2024-09-30 | |
| 2023-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-14 | $0.00 10-Q · filed 2024-02-14 | $1.33M derived: sum of 3 quarters · filed 2024-09-30 | $1.28M derived: sum of 4 quarters · filed 2024-09-30 | |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-14 | $1.33M derived: sum of 2 quarters · filed 2024-09-30 | $1.28M derived: sum of 3 quarters · filed 2024-09-30 | $1.46M derived: sum of 4 quarters · filed 2024-09-30 | |
| 2023-06-30 | $1.33M derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-30 | $1.28M derived: sum of 2 quarters · filed 2024-09-30 | $1.46M derived: sum of 3 quarters · filed 2024-09-30 | $1.01M 10-K · filed 2024-09-30 | |
| 2023-03-31 | -$56.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-15 | $129.00K derived: sum of 2 quarters · filed 2024-05-15 | -$327.00K 10-Q · filed 2024-05-15 | $11.18M derived: sum of 4 quarters · filed 2024-05-15 | |
| 2022-12-31 | $185.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-14 | -$271.00K 10-Q · filed 2024-02-14 | $11.24M derived: sum of 3 quarters · filed 2024-02-14 | $5.21M derived: sum of 4 quarters · filed 2024-02-14 | |
| 2022-09-30 | -$456.00K 10-Q · filed 2023-11-14 | $11.05M derived: sum of 2 quarters · filed 2023-11-14 | $5.02M derived: sum of 3 quarters · filed 2023-11-14 | $4.83M derived: sum of 4 quarters · filed 2023-11-14 | |
| 2022-06-30 | $11.51M derived: 10-K 12 month − 6-K 9 month · filed 2023-09-28 | $5.48M derived: sum of 2 quarters · filed 2023-09-28 | $5.28M derived: sum of 3 quarters · filed 2023-09-28 | $7.34M 10-K · filed 2023-09-28 | |
| 2022-03-31 | -$6.03M derived: 6-K 9 month − 6-K 6 month · filed 2023-06-09 | -$6.23M derived: sum of 2 quarters · filed 2023-06-09 | -$4.17M 6-K · filed 2023-06-09 | $4.17M 6-K · filed 2022-06-30 | -$4.16M derived: sum of 4 quarters · filed 2023-06-09 |
| 2021-12-31 | -$194.00K derived: 6-K 6 month − 6-K 3 month · filed 2023-03-30 | $1.86M 6-K · filed 2023-03-30 | $1.87M derived: sum of 3 quarters · filed 2023-03-30 | $952.00K derived: sum of 4 quarters · filed 2023-03-30 | |
| 2021-09-30 | $2.06M 6-K · filed 2022-11-30 | $2.06M derived: sum of 2 quarters · filed 2022-11-30 | $1.15M derived: sum of 3 quarters · filed 2022-11-30 | ||
| 2021-06-30 | $7.00K derived: 20-F 12 month − 6-K 9 month · filed 2022-10-31 | -$912.00K derived: sum of 2 quarters · filed 2022-10-31 | -$5.54M 20-F · filed 2022-10-31 | ||
| 2021-03-31 | -$919.00K derived: 6-K 9 month − 6-K/A 6 month · filed 2022-06-30 | -$5.55M 6-K · filed 2022-06-30 | |||
| 2020-12-31 | -$4.63M 6-K/A · filed 2022-04-29 | ||||
| 2020-06-30 | $213.00K 20-F · filed 2022-10-31 |